Limited utility of serum galactomannan assay after auto-SCT

Bone Marrow Transplantation

Volumn 44, Issue 1, 2009, Pages 59-61

  Jathavedam, A ^a   Dure D C ^a   Taur, Y ^a   Weinstock, D M ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; FLUCONAZOLE; GALACTOMANNAN; MICAFUNGIN; VORICONAZOLE;

ADOLESCENT; ADULT; AGED; ARTICLE; ASPERGILLOSIS; AUTOLOGOUS STEM CELL TRANSPLANTATION; CARBOHYDRATE ANALYSIS; CHILD; CONTROLLED STUDY; DIAGNOSTIC TEST; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; INFECTION PREVENTION; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SCREENING TEST;

ADOLESCENT; ASPERGILLOSIS; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MALE; MANNANS; NEOPLASMS; PREDICTIVE VALUE OF TESTS; TRANSPLANTATION, HOMOLOGOUS;

EID: 67651087103     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/bmt.2008.425     Document Type: Article

References (10)

1. Maertens J, Theunissen K, Verhoef G, Verschakelen J, Lagrou K, Verbeken E et al. Galactomannan and computed tomography-based preemptive antifungal therapy in neutropenic patients at high risk for invasive fungal infection: A prospective feasibility study. Clin Infect Dis 2005; 41: 1242-1250.
2. Marino IR, Panarello G, Singh N. Efficacy of Aspergillus galactomannan-directed preemptive therapy for the prevention of invasive aspergillosis in organ transplant recipients. Transpl Infect Dis 2002; 4: 226-227; authorr eply.
3. Maertens J, Deeren D, Dierickx D, Theunissen K. Preemptive antifungal therapy: Still a way to go. Curr Opin Infect Dis 2006; 19: 551-556.
4. Rapid test forAsper gillus infection. FDA Consum 2003; 37: 7.
5. Sinko J, CsomorJ, Nikolova R, Lueff S, Krivan G, Remenyi P et al. Invasive fungal disease in allogeneic hematopoietic stem cell transplant recipients: An autopsy-driven survey. Transpl Infect Dis 2008; 10: 106-109.
6. Steinbach WJ, Addison RM, McLaughlin L, Gerrald Q, Martin PL, Driscoll T et al. Prospective Aspergillus galactomannan antigen testing in pediatric hematopoietic stem cell transplant recipients. Pediatr Infect Dis J 2007; 26: 558-564.
7. Rooney S, Sekiguchi J, Zhu C, Cheng HL, Manis J, Whitlow S et al. Leaky Scid phenotype associated with defective V(D)J coding end processing in Artemis-deficient mice. Mol Cell 2002; 10: 1379-1390.
8. Pagano L, Caira M, Nosari A, Van Lint MT, Candoni A, Offidani M et al Fungal infections in recipients of hematopoietic stem cell transplants: Results of the SEIFEM B-2004 study - Sorveglianza Epidemiologica Infezioni Fungine Nelle Emopatie Maligne. Clin Infect Dis 2007; 45: 1161-1170.
9. Post MJ, Lass-Floerl C, Gastl G, Nachbaur D. Invasive fungal infections in allogeneic and autologous stem cell transplant recipients: A single-center study of 166 transplanted patients. Transpl Infect Dis 2007; 9: 189-195.
10. Ascioglu S, Rex JH, de Pauw B, Bennett JE, Bille J, Crokaert F et al Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: An international consensus. Clin Infect Dis 2002; 34: 7-14.